Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stephan Dietrich A Insider Profile
4 Followers
Stephan Dietrich A, President & CEO, Director, Ten Percent Owner at NeuBase Therapeutics, holds 2.56M shares in NeuBase Therapeutics (Ticker: NBSE). Most recently, Stephan Dietrich A Bought $1,275 shares of NeuBase Therapeutics on Jun 10, 2020 for an estimated value of 9.86K.
Stephan Dietrich A NeuBase Therapeutics (NBSE)President & CEO, Director, Ten Percent Owner
NeuBase Therapeutics (NBSE)
President & CEO, Director, Ten Percent Owner
Ranked #42,283 out of 78,624 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-2.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Stephan Dietrich A's holdings
Insider Roles
President & CEO, Director, Ten Percent Owner
Roles that Stephan Dietrich A holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 10, 2020 - Jun 10, 2021
Return:-0.30%
The most profitable trade made by Stephan Dietrich A
Stephan Dietrich A's Trading History
List of latest transactions for each holding click on a transaction to see Stephan Dietrich A's performance on stock
You May Also Like
Stephan Dietrich A insider profile FAQ
What is the percentage of profitable transactions made by Stephan Dietrich A?
The percentage of profitable transactions made by Stephan Dietrich A is 0%.
What is the average return per transaction made by Stephan Dietrich A?
The average return per transaction made by Stephan Dietrich A is -2.80%.
What stocks does Stephan Dietrich A hold?
Stephan Dietrich A holds: NBSE stocks.
What was Stephan Dietrich A’s latest transaction?
Stephan Dietrich A latest transaction was an Informative Buy of $9.86K.
What was Stephan Dietrich A's most profitable transaction?
Stephan Dietrich A’s most profitable transaction was an Informative Buy of NBSE stock on June 10, 2020. The return on the trade was -0.30%.
What is Stephan Dietrich A's role in NeuBase Therapeutics?
Stephan Dietrich A's role in NeuBase Therapeutics is President & CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.